Evidence map›Paper›PMID 21557709›Full record

ReviewExpert opinion on drug metabolism & toxicology2011

Reversible and irreversible protein glutathionylation: biological and clinical aspects.

Arthur Jl Cooper, John T Pinto, Patrick S Callery

Erratum issuedAbstract readReview
In one paragraph

Review in Expert opinion on drug metabolism & toxicology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Effects of Oral Liposomal Glutathione in Altering the Immune Responses AgainstFrontiers in cellular and infection microbiology · 2021
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Nuclear factor kappa B expression in non-small cell lung cancer.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Review
  8. Article
  9. Article
  10. Glutathione-Related Enzymes and Proteins: A Review.Molecules (Basel, Switzerland) · 2023
    Review
  11. Review
  12. Review
  13. Article
  14. MitochondrialAntioxidants (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Article
  17. Metabolic Shades of S-D-Lactoylglutathione.Antioxidants (Basel, Switzerland) · 2022
    Review
  18. Review
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors.

Arthur Jl CooperDepartment of Biochemistry and Molecular Biology, New York Medical College, 15 Dana Road, Valhalla, NY 10595, USA. arthur_cooper@nymc.edu
John T Pinto
Patrick S Callery

Funding

MECHANISM OF GLUTATHIONE CONJUGATE DEPENDENT TOXICITYR01ES008421 · NIEHS · WINIFRED MASTERSON BURKE MED RES INST · PI COOPER, ARTHUR JOSEPH · 1997 to 2007
$2.0M
Targets for selenium in prostate cancer preventionR01CA111842 · NCI · WINIFRED MASTERSON BURKE MED RES INST · PI PINTO, JOHN T · 2006 to 2009
$1.2M
NCI NIH HHS R01 CA111842NIEHS NIH HHS R01 ES008421PHS HHS R01 E508421
6 · The paper itself

Abstract

introductionDepending in part on the glutathione:glutathione disulfide ratio, reversible protein glutathionylation to a mixed disulfide may occur. Reversible glutathionylation is important in protecting proteins against oxidative stress, guiding correct protein folding, regulating protein activity and modulating proteins critical to redox signaling. The potential also exists for irreversible protein glutathionylation via Michael addition of an -SH group to a dehydroalanyl residue, resulting in formation of a stable, non-reducible thioether linkage. AREAS COVERED: This article reviews factors contributing to reversible and irreversible protein glutathionylation and their biomedical implications. It also examines the possibility that certain drugs such as busulfan may be toxic by promoting irreversible glutathionylation. The reader will gain an appreciation of the protective nature and control of function resulting from reversible protein glutathionylation. The reader is also introduced to the recently identified phenomenon of irreversible protein glutathionylation and its possible deleterious effects. EXPERT OPINION: The process of reversible protein glutathionylation is now well established but these findings need to be substantiated at the tissue and organ levels, and also with disease state. That being said, irreversible protein glutathionylation can also occur and this has implications in disease and aging. Toxicologists should consider this when evaluating the possible side effects of certain drugs such as busulfan that may generate a glutathionylating species in vivo.

Indexed as

Oxidative StressAlanineAldehydesAlzheimer DiseaseApoptosisBusulfanCataractCell CycleCystic FibrosisDiabetes Mellitus, Type 2GlutathioneGlutathione DisulfideGlutathione TransferaseNeoplasmsOxidation-ReductionProtein Folding4-oxo-2-nonenalAlanineAldehydesBusulfandehydroalanineGlutathioneGlutathione DisulfideGlutathione TransferaselanthionineProteinsSulfides

Identifiers

PMID21557709
PMCPMC3116085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.